Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 1
1993 2
1995 1
1996 3
1998 1
1999 2
2000 1
2001 2
2002 2
2003 2
2004 3
2005 2
2006 3
2007 4
2008 2
2009 12
2010 5
2011 6
2012 9
2013 10
2014 9
2015 11
2016 12
2017 10
2018 8
2019 12
2020 12
2021 11
2022 19
2023 26
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Results by year

Filters applied: . Clear all
Page 1
The effect of intermittent fasting diets on body weight and composition.
Erdem NZ, Bayraktaroğlu E, Samancı RA, Geçgil-Demir E, Tarakçı NG, Mert-Biberoğlu F. Erdem NZ, et al. Clin Nutr ESPEN. 2022 Oct;51:207-214. doi: 10.1016/j.clnesp.2022.08.030. Epub 2022 Aug 28. Clin Nutr ESPEN. 2022. PMID: 36184206 Clinical Trial.
METHODS: 360 people aged 18-65 years, with body mass index (BMI) between 27 and 35 kg/m(2) participated to the study. Demographic information, anthropometric measurements, physical activity and food consumption records were obtained by the researcher through weekly face-to …
METHODS: 360 people aged 18-65 years, with body mass index (BMI) between 27 and 35 kg/m(2) participated to the study. Demographic inf …
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
Wu YL, Dziadziuszko R, Ahn JS, Barlesi F, Nishio M, Lee DH, Lee JS, Zhong W, Horinouchi H, Mao W, Hochmair M, de Marinis F, Migliorino MR, Bondarenko I, Lu S, Wang Q, Ochi Lohmann T, Xu T, Cardona A, Ruf T, Noe J, Solomon BJ; ALINA Investigators. Wu YL, et al. N Engl J Med. 2024 Apr 11;390(14):1265-1276. doi: 10.1056/NEJMoa2310532. N Engl J Med. 2024. PMID: 38598794 Clinical Trial.
Re: Does structured withdrawal of desmopressin improve relapse rates in patients with monosymptomatic enuresis?: M. I. Gokce, P. Hajiyev, E. Suer, Y. Kibar, M. S. Silay, S. Gurocak, H. S. Dogan, H. C. Irkilata, T. Oktar, B. Onal, E. Erdem, Y. C. Aygun, C. Balci, A. R. Arslan, C. Kaya, T. Soygur, S. Sarikaya, S. Tekgul and B. Burgu, J Urol 2014;192:530-534.
Elkoushy MA. Elkoushy MA. J Urol. 2015 Apr;193(4):1446. doi: 10.1016/j.juro.2014.10.109. Epub 2015 Jan 10. J Urol. 2015. PMID: 25585344 No abstract available.
Letter to the editor regarding "Can urinary biomarkers detect obstruction defined by renal functional loss in antenatal hydronephrosis?" by Unsal Ozkuvanci, M. Irfan Donmez, Orhan Ziylan, Tayfun Oktar, Canan Kucukgergin, Bilal Cetin, Selcuk Erdem, Sule Seckin.
Pavlaki A, Kaselas C, Farmaki E, Papachristou F, Printza N. Pavlaki A, et al. J Pediatr Urol. 2021 Feb;17(1):122-123. doi: 10.1016/j.jpurol.2020.10.032. Epub 2020 Nov 15. J Pediatr Urol. 2021. PMID: 33250427 No abstract available.
Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical Trial.
Kishnani PS, Diaz-Manera J, Toscano A, Clemens PR, Ladha S, Berger KI, Kushlaf H, Straub V, Carvalho G, Mozaffar T, Roberts M, Attarian S, Chien YH, Choi YC, Day JW, Erdem-Ozdamar S, Illarioshkin S, Goker-Alpan O, Kostera-Pruszczyk A, van der Ploeg AT, An Haack K, Huynh-Ba O, Tammireddy S, Thibault N, Zhou T, Dimachkie MM, Schoser B; COMET Investigator Group. Kishnani PS, et al. JAMA Neurol. 2023 Jun 1;80(6):558-567. doi: 10.1001/jamaneurol.2023.0552. JAMA Neurol. 2023. PMID: 37036722 Free PMC article. Clinical Trial.
From baseline to week 97, LS mean (SE) FVC percent predicted increased by 2.65 (1.05) for those who continued avalglucosidase alfa and 0.36 (1.12) for those who switched to avalglucosidase alfa. The LS mean (SE) 6MWT distance increased by 18.60 (12.01) m and 4.56 (12.44) …
From baseline to week 97, LS mean (SE) FVC percent predicted increased by 2.65 (1.05) for those who continued avalglucosidase alfa and 0.36 …
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2024 May;14(4_suppl):690S-714S. doi: 10.1177/21925682241245615. Global Spine J. 2024. PMID: 38726630 Free PMC article. No abstract available.
A Sustainable Solution to Skin Diseases: Ecofriendly Transdermal Patches.
Yilmaz EG, Ece E, Erdem Ö, Eş I, Inci F. Yilmaz EG, et al. Pharmaceutics. 2023 Feb 8;15(2):579. doi: 10.3390/pharmaceutics15020579. Pharmaceutics. 2023. PMID: 36839902 Free PMC article. Review.
Skin is the largest epithelial surface of the human body, with a surface area of 2 m(2) for the average adult human. Being an external organ, it is susceptible to more than 3000 potential skin diseases, including injury, inflammation, microbial and viral infections, and sk …
Skin is the largest epithelial surface of the human body, with a surface area of 2 m(2) for the average adult human. Being an externa …
Renal effects of long-term lithium therapy, revisited.
Yazıcı MK, Özçelik Eroğlu E, Ertuğrul A, Anıl Yağcıoğlu AE, Ağaoğlu E, Karahan S, Eni N, Sağlam Aykut D, Kavak Ö, Erdem Y. Yazıcı MK, et al. Hum Psychopharmacol. 2022 Mar;37(2):e2812. doi: 10.1002/hup.2812. Epub 2021 Sep 20. Hum Psychopharmacol. 2022. PMID: 34541707
Proteinuria measured by spot urine protein/creatinine ratio can be detected even when eGFR is >90 ml/min/1.73 m(2) . Spot urine protein/creatinine ratio, which is a cost-effective and practical laboratory test, can be used to monitor lithium-treated patients....
Proteinuria measured by spot urine protein/creatinine ratio can be detected even when eGFR is >90 ml/min/1.73 m(2) . Spot urine pr …
Relationships among oncostatin M, insulin resistance, and chronic inflammation: a pilot study.
Akarsu M, Hursçitoglu M, Toprak Z, Yoldemir SA, Altun Ö, Toprak ID, Özcan M, Yürüyen G, Uğurlukişi B, Erdem MG, Kirna K, Demir P, Çapar G, Arman Y, Tükek T. Akarsu M, et al. Arch Endocrinol Metab. 2021 Apr 5;65(2):253. doi: 10.20945/2359-3997000000357. Arch Endocrinol Metab. 2021. PMID: 33826839 Free PMC article. No abstract available.
184 results